-
Diagnostics World News | Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology. Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies, and more.
Jan 7, 2020
-
Diagnostics World News | Last month NANOPEC Technologies announced MetaFluorex, a new class of proprietary nano-structured ceramic films, that the company says have shown to enhance fluorescent signals by factors as large as 100 times, depending on the assay, when compared to the glass slides currently used for in vitro diagnostic testing.
Jan 3, 2020
-
Diagnostics World News | A Duke University spin-out company is putting the last touches on a host response bacterial-viral test entering the final leg of the Antimicrobial Resistance (AMR) Diagnostic Challenge of the National Institutes of Health Division of Program Coordination, Planning, and Strategic Initiatives.
Jan 2, 2020
-
Diagnostics World News | December featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including Charles River, Takeda, Veracyte, and more.
Dec 23, 2019
-
Diagnostics World News | Researchers have known for a very long time that proteins circulating in human blood can, like the proverbial canary in the coal mine, be signals of health and disease risk. Until recently, the association has been exploited only in one-at-a-time experiments, usually with mass spectrometry technology.
Dec 19, 2019
-
Diagnostics World News | Ativa’s diagnostic workstation claims to be the only point-of-care system using a big-data approach to blood and urine testing to provide results on the major test panels used today to diagnose patients, and advanced diagnostic tests that gives deeper, more concise, disease information. If that sounds to you too good to be true, Ativa’s co-founder and CEO, is quick to point the company’s secrets to success: a team approach with solid partnerships, AI-driven analysis, and a seismic shift in the way data is collected for diagnostic testing.
Dec 18, 2019
-
Diagnostics World News | The Foundation for the National Institutes of Health is laser-focused on potentially transformative drug development tools that require group devotion to “not-so-sexy” science.
Dec 17, 2019
-
Diagnostics World News Brief | Ontera and QuantuMDx announced a collaboration this week to create a next-generation solution for blood stream infection and drug resistance detection. The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT, and Ontera’s powerful nanopore biosensor, currently used in their SAM and DUO Nano platforms.
Dec 12, 2019
-
Diagnostics World News Brief | Charles River announced that it has entered into an exclusive Discovery and Safety Services partnership with Bit Bio, a company that offers consistent and efficient reprogramming of human cells for use in research, drug discovery, and cell therapies.
Dec 11, 2019